Global Diabetic Macular Edema Treatment Market to Reach $4.9 Billion by 2030
The global market for Diabetic Macular Edema Treatment estimated at US$4.1 Billion in the year 2022, is projected to reach a revised size of US$4.9 Billion by 2030, growing at a CAGR of 2.1% over the analysis period 2022-2030. Anti-VEGF, one of the segments analyzed in the report, is projected to record 2.4% CAGR and reach US$2.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Corticosteroid segment is readjusted to a revised 2% CAGR for the next 8-year period.The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 1.8% CAGR
The Diabetic Macular Edema Treatment market in the U.S. is estimated at US$1.2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$855.8 Million by the year 2030 trailing a CAGR of 1.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.1% and 1.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.Select Competitors (Total 38 Featured) -
- Acucela Inc.
- Aerie Pharmaceuticals, Inc.
- Aerpio Pharmaceuticals
- Antisense Therapeutics Limited
- Araim Pharmaceuticals, Inc.
- BCN Peptides S.A.
- Biomar Microbial Technologies
- Charlesson LLC
- Coherus BioSciences
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
REST OF WORLD
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Acucela Inc.
- Aerie Pharmaceuticals, Inc.
- Aerpio Pharmaceuticals
- Antisense Therapeutics Limited
- Araim Pharmaceuticals, Inc.
- BCN Peptides S.A.
- Biomar Microbial Technologies
- Charlesson LLC
- Coherus BioSciences
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 192 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 4.1 Billion |
Forecasted Market Value ( USD | $ 4.9 Billion |
Compound Annual Growth Rate | 2.3% |
Regions Covered | Global |